系所介绍

复旦大学现代物理研究所(核科学与技术系)简介

发布时间:2025-05-07

复旦大学现代物理研究所(核科学与技术系)前身可追溯至1958年成立的原子能系,历经物理二系、原子核科学系等发展阶段,是我国高校首批设立原子核物理专业的教育科研机构之一。1997年改组为现代物理研究所,专注科研与研究生培养;2009年增设核科学与技术系,恢复本科生教育。

作为我国核科学与技术领域的重要研究基地,本研究所在吴征铠、卢鹤绂、杨福家等院士的引领下,历经数代师生建设,形成了深厚的研究积淀与人才培养体系。目前设有物理学(核物理方向)、核工程与核技术两个本科专业,拥有粒子物理与原子核物理、原子与分子物理、等

离子体物理三个硕士学位点,以及粒子物理与原子核物理、原子与分子物理两个博士学位点。自1958年至今,累计培养本科生3000余人、硕士300余人、博士200余人,校友中涌现出胡思得、朱祖良、欧阳晓平等核事业领军人物,以及陈凯先、柴之芳等核科学与生命健康交叉领域的开拓者。

研究所现有专任教师60余名,其中高层次人才占比超过30%,形成以院士团队为核心、国家级科研骨干为中坚的国际化研究队伍。依托国家基金委上海核物理理论研究中心、核物理与离子束应用实验室教育部重点实验室、教育部重离子物理创新引智基地等科研平台,承担国家基金委重大项目、科技部重点研发计划等国家级课题百余项。2022至2024年连续三年发表论文超百篇,近四年在Nature、Nature Material、Nature Physics、Nature Communication、Physical Review Letters等顶尖期刊发表论文近30篇。深度参与美国布鲁克海文国家实验室RHIC-STAR实验、欧洲核子中心LHC-ALICE实验、日本高能加速器机构KEK Belle与Belle II 实验、中国北京BESIII实验等大科学装置国际合作项目,并与中国工程物理研究院、中科院近代物理研究所、中科院上海应用物理研究所等国内机构保持密切合作。

学科建设聚焦:

  1. 核物理与粒子物理:依托国内外大科学装置,开展重离子物理、量子色动力学物质、强子物理、味物理、中微子物理、反物质与暗物质等前沿研究,主导探测器研发与国际实验合作。

  2. 原子与分子物理:基于自主建设的电子束离子阱等平台,研究高电荷态离子物理、量子精密测量及等离子体诊断技术。

  3. 核技术及其应用:围绕离子束分析、材料辐照效应、裂变与聚变工程等方向,推进核技术在能源、材料、医学等领域的应用。

  4. 理论与计算物理:通过高性能计算平台,探索核结构理论、新型加速器原理及多物理场耦合模拟。

  5. 交叉学科拓展:重点布局光核物理、先进核能、核天体物理、生物医学核技术四大融合领域。

当前,研究所全面推进“三五四”发展战略:坚持理论、实验、应用三大研究范式协同发展,巩固核物理与粒子物理的学科优势,强化核技术应用等方向的国内竞争力,着力开拓交叉学科新增长点,持续提升学科国际影响力与科研创新能级。


Institute of Modern Physics

(Department of Nuclear Science and Technology)

Fudan University

The Institute of Modern Physics (IMP) at Fudan University, formerly the Department of Nuclear Science and Technology, traces its origins to the Department of Atomic Energy established in 1958. Over the decades, it evolved through various stages, including the Department of Physics II and the Department of Nuclear Science, making it one of China’s earliest institutions dedicated to nuclear physics education and research. In 1997, it was restructured into the Institute of Modern Physics, focusing on scientific research and graduate education. Undergraduate programs were reinstated in 2009 with the establishment of the Department of Nuclear Science and Technology.

As a pivotal research and talent cultivation base in China’s nuclear science and technology field, the institute has built a profound academic legacy under the guidance of distinguished academicians such as Prof. Wu Zhengkai, Prof. Lu Hefu, and Prof. Yang Fujia. It currently offers two undergraduate programs: Physics (Nuclear Physics Specialization) and Nuclear Engineering and Nuclear Technology. At the graduate level, it hosts three master’s programs (Particle Physics and Nuclear Physics, Atomic and Molecular Physics, and Plasma Physics) and two doctoral programs (Particle Physics and Nuclear Physics and Atomic and Molecular Physics). Since 1958, the institute has educated over 3,000 undergraduates, 300 master’s students, and 200 doctoral candidates. Its alumni include leading figures in nuclear science such as Prof. Hu Side, Prof. Zhu Zuliang, and Prof. Ouyang Xiaoping, as well as interdisciplinary pioneers like Prof. Chen Kaixian and Prof. Chai Zhifang, who have advanced the integration of nuclear science with life sciences and healthcare.

The institute currently has over 60 full-time faculty members, with more than 30% selected into national-level high-tier talent programs. It boasts an internationally competitive research team led by three academicians—Prof. Ma Yugang, Prof. Hu Side, and Prof. Shen Wenqing—and supported by a core of NSFC Distinguished Young Scholars) and national-level young talent program recipients (e.g., Four Youth Talents).Equipped with major research platforms such as the Shanghai Center for Theoretical Nuclear Physics (NSFC),Key Laboratory of Nuclear Physics and Ion Beam Applications (Ministry of Education), and the Innovation Center for Heavy Ion Physics Research (Ministry of Education), the institute has undertaken over 100 national projects, including NSFC major initiatives and Ministry of Science and Technology key R&D programs. From 2022 to 2024, it published over 100 research papers annually, with nearly 30 appearing in top-tier journals such as Nature, Nature Materials, Nature Physics, Nature Communications, and Physical Review Letters in the past four years.

The institute actively participates in international mega-science projects, including the RHIC-STAR experiment at Brookhaven National Laboratory (USA), the LHC-ALICE experiment at CERN (Europe), the KEK Belle and Belle II experiments in Japan, and the BESIII experiment in Beijing. Domestically, it collaborates closely with institutions such as the China Academy of Engineering Physics, the Institute of Modern Physics (Chinese Academy of Sciences), and the Shanghai Institute of Applied Physics.

Research Focus Areas:

1. Nuclear and Particle Physics: Cutting-edge studies on heavy-ion physics, Quantum Chromodynamics matter, hadron physics, flavor physics, neutrino physics, antimatter, and dark matter, supported by international facilities and leading roles in detector development.

2. Atomic and Molecular Physics: Research on highly charged ions, quantum precision measurement, and plasma diagnostics using self-developed platforms like the electron beam ion trap.

3. Nuclear Technology and Applications: Advancements in ion beam analysis, material irradiation effects, fission/fusion engineering, and applications in energy, materials, and medicine.

4. Theoretical and Computational Physics: Exploration of nuclear structure theory, novel accelerator principles, and multiphysics simulations via high-performance computing.

5. Interdisciplinary Frontiers: Integration of nuclear science with photonics, advanced nuclear energy, nuclear astrophysics, and biomedical technologies.

Currently, the institute is advancing its Three-Five-Four development strategy:

• Three Paradigms: Synergy among theoretical, experimental, and applied research.

• Five Core Strengths: Consolidating leadership in nuclear/particle physics, enhancing competitiveness in nuclear technology, and fostering interdisciplinary innovation.

• Four Growth Areas: Expanding frontiers in photonic nuclear physics, next-generation nuclear energy, nuclear astrophysics, and biomedical applications.

 This strategy aims to elevate the institute’s global academic impact and drive transformative advancements in nuclear science and technology.